153 related articles for article (PubMed ID: 29523558)
1. Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems.
Kaufmann CP; Stämpfli D; Mory N; Hersberger KE; Lampert ML
BMJ Open; 2018 Mar; 8(3):e016610. PubMed ID: 29523558
[TBL] [Abstract][Full Text] [Related]
2. Assessing the ability of the Drug-Associated Risk Tool (DART) questionnaire to stratify hospitalised older patients according to their risk of drug-related problems: a cross-sectional validation study.
Stämpfli D; Boeni F; Gerber A; Bättig VAD; Weidmann R; Hersberger KE; Lampert ML
BMJ Open; 2018 Jun; 8(6):e021284. PubMed ID: 29950469
[TBL] [Abstract][Full Text] [Related]
3. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.
Covert KL; Mardis CR; Fleming JN; Pilch NA; Meadows HB; Mardis BA; Mohan P; Posadas-Salas M; Srinivas T; Taber DJ
Pharmacotherapy; 2017 Feb; 37(2):159-169. PubMed ID: 27997676
[TBL] [Abstract][Full Text] [Related]
4. Drug-related problems identified by pharmacist-led medication review in Slovak hospitalised patients.
Kováčová B; ĎuriŽová A
Pharmazie; 2016 Sep; 71(9):548-551. PubMed ID: 29441854
[TBL] [Abstract][Full Text] [Related]
5. Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey.
Abunahlah N; Elawaisi A; Velibeyoglu FM; Sancar M
Int J Clin Pharm; 2018 Apr; 40(2):360-367. PubMed ID: 29380236
[TBL] [Abstract][Full Text] [Related]
6. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals.
Blix HS; Viktil KK; Reikvam A; Moger TA; Hjemaas BJ; Pretsch P; Vraalsen TF; Walseth EK
Eur J Clin Pharmacol; 2004 Nov; 60(9):651-8. PubMed ID: 15568140
[TBL] [Abstract][Full Text] [Related]
7. Assessment of drug-related problems in pediatric ward of Zewditu Memorial Referral Hospital, Addis Ababa, Ethiopia.
Birarra MK; Heye TB; Shibeshi W
Int J Clin Pharm; 2017 Oct; 39(5):1039-1046. PubMed ID: 28689305
[TBL] [Abstract][Full Text] [Related]
8. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs).
Viktil KK; Blix HS; Moger TA; Reikvam A
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):667-74. PubMed ID: 16598835
[TBL] [Abstract][Full Text] [Related]
9. Drug-related problems identified during medication review before and after the introduction of a clinical decision support system.
Verdoorn S; Kwint HF; Hoogland P; Gussekloo J; Bouvy ML
J Clin Pharm Ther; 2018 Apr; 43(2):224-231. PubMed ID: 28971492
[TBL] [Abstract][Full Text] [Related]
10. Assessment tool for hospital admissions related to medications: development and validation in older patients.
Kempen TGH; Hedström M; Olsson H; Johansson A; Ottosson S; Al-Sammak Y; Gillespie U
Int J Clin Pharm; 2019 Feb; 41(1):198-206. PubMed ID: 30585296
[TBL] [Abstract][Full Text] [Related]
11. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process.
Kaufmann CP; Stämpfli D; Hersberger KE; Lampert ML
BMJ Open; 2015 Mar; 5(3):e006376. PubMed ID: 25795686
[TBL] [Abstract][Full Text] [Related]
12. Drug-related problems identified during geriatric medication review in the community pharmacy.
Rhalimi M; Rauss A; Housieaux E
Int J Clin Pharm; 2018 Feb; 40(1):109-118. PubMed ID: 29188412
[TBL] [Abstract][Full Text] [Related]
13. The Impact of an Established Pharmaceutical Care Pathway on Drug Related Problems in an Intensive Care Unit.
Toukhy A; Fayed S; Sabry N; Shawki M
Am J Med Sci; 2021 Aug; 362(2):143-153. PubMed ID: 33745978
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of criteria for classifying severity of drug-related problems in chronic kidney disease: A community pharmacy perspective.
Quintana-Bárcena P; Lord A; Lizotte A; Berbiche D; Jouini G; Lalonde L
Am J Health Syst Pharm; 2015 Nov; 72(21):1876-84. PubMed ID: 26490822
[TBL] [Abstract][Full Text] [Related]
15. Drug-related problems in patients with ischemic stroke in hospital.
Hohmann C; Neumann-Haefelin T; Klotz JM; Freidank A; Radziwill R
Int J Clin Pharm; 2012 Dec; 34(6):828-31. PubMed ID: 22915264
[TBL] [Abstract][Full Text] [Related]
16. Information on actual medication use and drug-related problems in older patients: questionnaire or interview?
Willeboordse F; Grundeken LH; van den Eijkel LP; Schellevis FG; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Apr; 38(2):380-7. PubMed ID: 26830412
[TBL] [Abstract][Full Text] [Related]
17. EPICC study: evaluation of pharmaceutical intervention in cancer care.
Vantard N; Ranchon F; Schwiertz V; Gourc C; Gauthier N; Guedat MG; He S; Kiouris E; Alloux C; You B; Souquet PJ; Freyer G; Salles G; Trillet-Lenoir V; Rioufol C
J Clin Pharm Ther; 2015 Apr; 40(2):196-203. PubMed ID: 25594148
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Community Pharmacy-Based Screening Questionnaire to Identify Patients at Risk for Drug Therapy Problems.
Pammett RT; Blackburn D; Taylor J; Mansell K; Kwan D; Papoushek C; Jorgenson D
Pharmacotherapy; 2015 Sep; 35(9):881-6. PubMed ID: 26406776
[TBL] [Abstract][Full Text] [Related]
19. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study.
Belaiche S; Romanet T; Allenet B; Calop J; Zaoui P
J Nephrol; 2012; 25(5):782-8. PubMed ID: 22322820
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams.
Blix HS; Viktil KK; Moger TA; Reikvam A
Pharm World Sci; 2006 Jun; 28(3):152-8. PubMed ID: 17004023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
